Adsorption Behavior and Mechanism of Antibiotic Sulfamethoxazole on Carboxylic-Functionalized Carbon Nanofibers-Encapsulated Ni Magnetic Nanoparticles.

In this work we developed a one-step process for synthesizing carboxylic-functionalized carbon nanofibers (CNFs)-encapsulated Ni magnetic nanoparticles (Ni@CNFs) that exhibit an excellent magnetic response and a large content of hydrophilic carboxylate groups with a negative charge (RCOO(-)) on the carbon surface. The carbon-encapsulated magnetic Ni nanoparticles could be rapidly separated from water, and they showed high efficiency for adsorption of the antibiotic sulfamethoxazole (SMX) in aqueous solution. The adsorption of SMX on Ni@CNFs as a function of pH was investigated, and the greatest adsorption occurred at pH 7.0. The adsorption isotherms for SMX on Ni@CNFs depended on different pH values. A Monte Carlo simulation was used to probe the relationship between molecular conformation and π-π interaction. The high adsorption of SMX on Ni@CNFs at pH 7.0 could be ascribed to deprotonated SMX being easily converted to a planar-like conformation, thereby resulting in the formation of π rings that were approximately parallel to the graphite surface and that enhanced strong π-π interaction. Electrostatic and π-π interactions both contributed to deprotonated SMX adsorption at pH 7.0, and they influenced the adsorption isotherm toward the Freundlich model. However, in weakly acidic environments (pH 2.0 and 4.0), the electrostatic interaction alone could induce an adsorption pattern that was similar to the Langmuir model.

Effect of Ti3+ on TiO2-supported Cu catalysts used for CO oxidation.

In this paper, we have shown that Cu/TiO(2) catalysts are highly active in CO oxidation. For instance, a 3.4% Cu/TiO(2) catalyst exhibits a higher turnover rate for the effective removal of CO in air than 3-5% Pt/TiO(2) and 20% Cu/ZnO/Al(2)O(3) catalysts. A small amount of Cu(+) species is formed during the calcination treatment at 225 °C, which is the main active phase for the CO oxidation. However, it is proposed that some highly dispersed CuO can also form in the TiO(2) lattice during the calcination treatment. Furthermore, a strong electron interaction between Cu(2+) in highly dispersed CuO and Ti(3+) on rutile TiO(2) (Cu(2+)+Ti(3+)→Cu(+)+Ti(4+)) has been shown to occur. Overall, the reduction of Cu(+) is a major factor that contributes to the reaction rate of the CO oxidation.

Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma.

BACKGROUND: The aim of this study was to assess the validity of the 7th edition of the American Joint Committee on Cancer (AJCC) TNM system (TNM-7) for patients undergoing hepatectomy for hepatocellular carcinoma (HCC). METHODS: Partial hepatectomies performed for 879 patients from 1993 to 2005 were retrospectively reviewed. Clinicopathological factors, surgical outcome, overall survival (OS), and disease-free survival (DFS) were analyzed to evaluate the predictive value of the TNM-7 staging system. RESULTS: According to the TNM-7 system, differences in five-year survival between stages I, II, and III were statistically significant. Subgroup analysis of stage III patients revealed that the difference between stages II and IIIA was not significant (OS, p = 0.246; DFS, p = 0.105). Further stratification of stages IIIA, IIIB and IIIC also did not reveal significant differences. Cox proportional hazard models of stage III analyses identified additional clinicopathological factors affecting patient survival: lack of tumor encapsulation, aspartate aminotransferase (AST) values > 68 U/L, and blood loss > 500 mL affected DFS whereas lack of tumor encapsulation, AST values > 68 U/L, blood loss > 500 mL, and serum α-fetoprotein (AFP) values > 200 ng/mL were independent factors impairing OS. Stage III factors including tumor thrombus, satellite lesions, and tumor rupture did not appear to influence survival in the stage III subgroup. CONCLUSIONS: In terms of 5-year survival rates, the TNM-7 system is capable of stratifying post-hepatectomy HCC patients into stages I, II, and III but is unable to stratify stage III patients into stages IIIA, IIIB and IIIC. Lack of tumor encapsulation, AST values > 68 U/L, blood loss > 500 mL, and AFP values > 200 ng/mL are independent prognostic factors affecting long-term survival.